WORK OVERVIEW
As a result of the GCP monitoring of their Phase I trial in Aalborg of the candidate drug E-52862, a pain killer of the S1RA category, we are continuing the contact and we are now discussing the possibility of performing new clinical trials in Denmark (Phase IIB/ III).
0 Likes